| Variable . | PAEs ( N = 18) . | No PAEs ( N = 43) . | P -value . |
|---|---|---|---|
| Sex (female) | 10 (55.6%) | 13 (30.2%) | 0.085 |
| Age at initial PVR (years) | 9.4 ± 8.1 | 7.4 ± 4.1 | 0.52 |
| Age at redo PVR (years) | 15.2 ± 8.3 | 14.9 ± 4.8 | 0.47 |
| Weight (kg) | 42.5 ± 20.9 | 47.0 ± 14.8 | 0.13 |
| BSA (m 2 ) | 1.30 ± 0.37 | 1.42 ± 0.29 | 0.12 |
| Number of prior operations | 3 ± 1 | 3 ± 1 | 0.48 |
| Number of prior sternotomies | 2 ± 1 | 2 ± 1 | 0.96 |
| Valve size used for initial PVR | 21 ± 3 | 21 ± 2 | 0.81 |
| Pericardial closure with PTFE membrane at initial PVR | 11 (61.1%) | 32 (74.4%) | 0.36 |
| RV systolic pressure ( n = 54, mmHg) | 105 ± 22 | 89 ± 19 | 0.016 |
| Peak pressure gradient across the PV ( n = 60, mmHg) | 59 ± 27 | 63 ± 20 | 0.57 |
| Tricuspid regurgitation grade ≥ moderate | 4 (22.2%) | 7 (16.3%) | 0.72 |
| Preoperative catheter intervention for the PV | 9 (50.0%) | 10 (23.3%) | 0.067 |
| Indication of infective endocarditis for redo PVR | 4 (22.2%) | 4 (9.3%) | 0.22 |
| NYHA class ≥II | 10 (55.6%) | 21 (48.8%) | 0.78 |
| Re-entry injury | 2 (11.1%) | 0 (0%) | 0.084 |
| Concomitant procedures | 10 (55.6%) | 22 (51.2%) | 0.79 |
| Cardiopulmonary bypass time (min) | 219 ± 77 | 164 ± 59 | 0.007 |
| Aortic cross-clamp time ( n = 34, min) | 101 ± 89 | 90 ± 41 | 0.91 |
| Variable . | PAEs ( N = 18) . | No PAEs ( N = 43) . | P -value . |
|---|---|---|---|
| Sex (female) | 10 (55.6%) | 13 (30.2%) | 0.085 |
| Age at initial PVR (years) | 9.4 ± 8.1 | 7.4 ± 4.1 | 0.52 |
| Age at redo PVR (years) | 15.2 ± 8.3 | 14.9 ± 4.8 | 0.47 |
| Weight (kg) | 42.5 ± 20.9 | 47.0 ± 14.8 | 0.13 |
| BSA (m 2 ) | 1.30 ± 0.37 | 1.42 ± 0.29 | 0.12 |
| Number of prior operations | 3 ± 1 | 3 ± 1 | 0.48 |
| Number of prior sternotomies | 2 ± 1 | 2 ± 1 | 0.96 |
| Valve size used for initial PVR | 21 ± 3 | 21 ± 2 | 0.81 |
| Pericardial closure with PTFE membrane at initial PVR | 11 (61.1%) | 32 (74.4%) | 0.36 |
| RV systolic pressure ( n = 54, mmHg) | 105 ± 22 | 89 ± 19 | 0.016 |
| Peak pressure gradient across the PV ( n = 60, mmHg) | 59 ± 27 | 63 ± 20 | 0.57 |
| Tricuspid regurgitation grade ≥ moderate | 4 (22.2%) | 7 (16.3%) | 0.72 |
| Preoperative catheter intervention for the PV | 9 (50.0%) | 10 (23.3%) | 0.067 |
| Indication of infective endocarditis for redo PVR | 4 (22.2%) | 4 (9.3%) | 0.22 |
| NYHA class ≥II | 10 (55.6%) | 21 (48.8%) | 0.78 |
| Re-entry injury | 2 (11.1%) | 0 (0%) | 0.084 |
| Concomitant procedures | 10 (55.6%) | 22 (51.2%) | 0.79 |
| Cardiopulmonary bypass time (min) | 219 ± 77 | 164 ± 59 | 0.007 |
| Aortic cross-clamp time ( n = 34, min) | 101 ± 89 | 90 ± 41 | 0.91 |
Data are presented as means with standard deviations or frequencies with percentages as appropriate.
BSA: body surface area; NYHA: New York Heart Association; PAEs: postoperative adverse events; PTFE: polytetrafluoroethylene; PV: pulmonary valve; PVR: pulmonary valve replacement; RV: right ventricular.
| Variable . | PAEs ( N = 18) . | No PAEs ( N = 43) . | P -value . |
|---|---|---|---|
| Sex (female) | 10 (55.6%) | 13 (30.2%) | 0.085 |
| Age at initial PVR (years) | 9.4 ± 8.1 | 7.4 ± 4.1 | 0.52 |
| Age at redo PVR (years) | 15.2 ± 8.3 | 14.9 ± 4.8 | 0.47 |
| Weight (kg) | 42.5 ± 20.9 | 47.0 ± 14.8 | 0.13 |
| BSA (m 2 ) | 1.30 ± 0.37 | 1.42 ± 0.29 | 0.12 |
| Number of prior operations | 3 ± 1 | 3 ± 1 | 0.48 |
| Number of prior sternotomies | 2 ± 1 | 2 ± 1 | 0.96 |
| Valve size used for initial PVR | 21 ± 3 | 21 ± 2 | 0.81 |
| Pericardial closure with PTFE membrane at initial PVR | 11 (61.1%) | 32 (74.4%) | 0.36 |
| RV systolic pressure ( n = 54, mmHg) | 105 ± 22 | 89 ± 19 | 0.016 |
| Peak pressure gradient across the PV ( n = 60, mmHg) | 59 ± 27 | 63 ± 20 | 0.57 |
| Tricuspid regurgitation grade ≥ moderate | 4 (22.2%) | 7 (16.3%) | 0.72 |
| Preoperative catheter intervention for the PV | 9 (50.0%) | 10 (23.3%) | 0.067 |
| Indication of infective endocarditis for redo PVR | 4 (22.2%) | 4 (9.3%) | 0.22 |
| NYHA class ≥II | 10 (55.6%) | 21 (48.8%) | 0.78 |
| Re-entry injury | 2 (11.1%) | 0 (0%) | 0.084 |
| Concomitant procedures | 10 (55.6%) | 22 (51.2%) | 0.79 |
| Cardiopulmonary bypass time (min) | 219 ± 77 | 164 ± 59 | 0.007 |
| Aortic cross-clamp time ( n = 34, min) | 101 ± 89 | 90 ± 41 | 0.91 |
| Variable . | PAEs ( N = 18) . | No PAEs ( N = 43) . | P -value . |
|---|---|---|---|
| Sex (female) | 10 (55.6%) | 13 (30.2%) | 0.085 |
| Age at initial PVR (years) | 9.4 ± 8.1 | 7.4 ± 4.1 | 0.52 |
| Age at redo PVR (years) | 15.2 ± 8.3 | 14.9 ± 4.8 | 0.47 |
| Weight (kg) | 42.5 ± 20.9 | 47.0 ± 14.8 | 0.13 |
| BSA (m 2 ) | 1.30 ± 0.37 | 1.42 ± 0.29 | 0.12 |
| Number of prior operations | 3 ± 1 | 3 ± 1 | 0.48 |
| Number of prior sternotomies | 2 ± 1 | 2 ± 1 | 0.96 |
| Valve size used for initial PVR | 21 ± 3 | 21 ± 2 | 0.81 |
| Pericardial closure with PTFE membrane at initial PVR | 11 (61.1%) | 32 (74.4%) | 0.36 |
| RV systolic pressure ( n = 54, mmHg) | 105 ± 22 | 89 ± 19 | 0.016 |
| Peak pressure gradient across the PV ( n = 60, mmHg) | 59 ± 27 | 63 ± 20 | 0.57 |
| Tricuspid regurgitation grade ≥ moderate | 4 (22.2%) | 7 (16.3%) | 0.72 |
| Preoperative catheter intervention for the PV | 9 (50.0%) | 10 (23.3%) | 0.067 |
| Indication of infective endocarditis for redo PVR | 4 (22.2%) | 4 (9.3%) | 0.22 |
| NYHA class ≥II | 10 (55.6%) | 21 (48.8%) | 0.78 |
| Re-entry injury | 2 (11.1%) | 0 (0%) | 0.084 |
| Concomitant procedures | 10 (55.6%) | 22 (51.2%) | 0.79 |
| Cardiopulmonary bypass time (min) | 219 ± 77 | 164 ± 59 | 0.007 |
| Aortic cross-clamp time ( n = 34, min) | 101 ± 89 | 90 ± 41 | 0.91 |
Data are presented as means with standard deviations or frequencies with percentages as appropriate.
BSA: body surface area; NYHA: New York Heart Association; PAEs: postoperative adverse events; PTFE: polytetrafluoroethylene; PV: pulmonary valve; PVR: pulmonary valve replacement; RV: right ventricular.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
